Nanoparticulate CpG Immunotherapy in RAO‐Affected Horses: Phase I and IIa Study

por Klier, J., Lehmann, B., Fuchs, S., Reese, S., Hirschmann, A., Coester, C., Winter, G., Gehlen, H.
Publicado 2015

EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer

por Varella-Garcia, M, Diebold, J, Eberhard, D A, Geenen, K, Hirschmann, A, Kockx, M, Nagelmeier, I, Rüschoff, J, Schmitt, M, Arbogast, S, Cappuzzo, F
Publicado 2009